These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1801636)

  • 21. Oral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection with Pseudomonas aeruginosa.
    Collins HH; Cross AS; Dobek A; Opal SM; McClain JB; Sadoff JC
    J Infect Dis; 1989 Jun; 159(6):1073-82. PubMed ID: 2723454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
    Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
    Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].
    Kolker II; Stanislavskiĭ ES; Grishina IA; Panova IuM; Krokhina MA
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):29-33. PubMed ID: 6784114
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects].
    Stanislavskiĭ ES; Joó I
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):22-31. PubMed ID: 6414198
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
    Orłowski T; Struzyna J; Badowski A; Schiller B; Kuntze A; Kozaczek W; Goller W
    Wiad Lek; 1980 Nov; 33(21):1697-701. PubMed ID: 6784349
    [No Abstract]   [Full Text] [Related]  

  • 26. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral ciprofloxacin for treatment of infection following nail puncture wounds of the foot.
    Raz R; Miron D
    Clin Infect Dis; 1995 Jul; 21(1):194-5. PubMed ID: 7578730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ; Meadow PM; Fürer E; Germanier R
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.
    Oishi K; Sonoda F; Iwagaki A; Ponglertnapagorn P; Watanabe K; Nagatake T; Siadak A; Pollack M; Matsumoto K
    Antimicrob Agents Chemother; 1993 Feb; 37(2):164-70. PubMed ID: 8383936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic epitope in Pseudomonas aeruginosa lipopolysaccharide immunologically cross-reactive with Escherichia coli O26 lipopolysaccharide.
    Yokota S; Kaya S; Noguchi H
    FEMS Microbiol Lett; 1990 Mar; 56(3):245-8. PubMed ID: 1692796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccharides.
    Sadoff JC; Wright DC; Futrovsky S; Sidberry H; Collins H; Kaufmann B
    Antibiot Chemother (1971); 1985; 36():134-46. PubMed ID: 3923911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dr Coetzee responds.
    Coetzee E
    S Afr J Surg; 2013 Nov; 51(4):152. PubMed ID: 24479209
    [No Abstract]   [Full Text] [Related]  

  • 36. [Investigation on the protection of mice from infection with Pseudomonas aeruginosa using monoclonal antibodies].
    Ye DN; Wang CX; Yan RH; Dai BM; Ni HY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):188-90. PubMed ID: 3939267
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody response to outer-membrane antigens of Pseudomonas aeruginosa in human burn wound infection.
    Ward KH; Anwar H; Brown RW; Wale J; Gowar J
    J Med Microbiol; 1988 Nov; 27(3):179-90. PubMed ID: 3143013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas aeruginosa infection: pathogenesis and therapy.
    Pennington JE
    Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
    [No Abstract]   [Full Text] [Related]  

  • 39. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa.
    Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Pier GB; Puckett JM; Sewell TJ; Sigal NH
    Infect Immun; 1988 May; 56(5):1209-14. PubMed ID: 3128480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies against Pseudomonas aeruginosa outer membrane antigens: isolation and characterization.
    Hancock RE; Wieczorek AA; Mutharia LM; Poole K
    Infect Immun; 1982 Jul; 37(1):166-71. PubMed ID: 6809625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.